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Objective: We have recently shown that acute inhibition of both mTOR complexes (mTORC1 and mTORC2) increases whole-body lipid utilization,
while mTORC1 inhibition had no effect. Therefore, we tested the hypothesis that mTORC2 regulates lipid metabolism in skeletal muscle.
Methods: Body composition, substrate utilization and muscle lipid storage were measured in mice lacking mTORC2 activity in skeletal muscle
(speciﬁc knockout of RICTOR (Ric mKO)). We further examined the RICTOR/mTORC2-controlled muscle metabolome and proteome; and per-
formed follow-up studies in other genetic mouse models and in cell culture.
Results: Ric mKO mice exhibited a greater reliance on fat as an energy substrate, a re-partitioning of lean to fat mass and an increase in
intramyocellular triglyceride (IMTG) content, along with increases in several lipid metabolites in muscle. Unbiased proteomics revealed an in-
crease in the expression of the lipid droplet binding protein Perilipin 3 (PLIN3) in muscle from Ric mKO mice. This was associated with increased
AMPK activity in Ric mKO muscle. Reducing AMPK kinase activity decreased muscle PLIN3 expression and IMTG content. AMPK agonism, in turn,
increased PLIN3 expression in a FoxO1 dependent manner. PLIN3 overexpression was sufﬁcient to increase triglyceride content in muscle cells.
Conclusions: We identiﬁed a novel link between mTORC2 and PLIN3, which regulates lipid storage in muscle. While mTORC2 is a negative
regulator, we further identiﬁed AMPK as a positive regulator of PLIN3, which impacts whole-body substrate utilization and nutrient partitioning.
 2016 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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The mammalian target of rapamycin (mTOR) is a serine/threonine
protein kinase that is found in two distinct mTOR complexes, mTOR
complex 1 (mTORC1) and mTORC2. RAPTOR (regulatory-associated
protein of mTOR) is the deﬁning subunit of mTORC1, which is a vital
regulator of cell growth. The subunits RICTOR (rapamycin-insensitive
companion of mTOR) and SIN1 (SAPK-interacting protein 1) are unique
to mTORC2. Growth factors activate mTORC2 [31,45], and its sub-
strates include Akt, SGK1, and PKCa. As a kinase for Akt Ser473
phosphorylation [34], mTORC2 is positioned in the canonical insulin
signaling pathway responsible for regulating glucose uptake. There-
fore, it is not surprising that in adipose tissue [11,25] and in liver
[14,26,43] mTORC2 is required for maintaining glucose homeostasis.
Similarly, evidence from cultured muscle cells [42] and incubated
mouse skeletal muscles [24] implicated mTORC2 as a regulator of
muscle glucose metabolism. In agreement, muscle speciﬁc RICTOR
knockout (Ric mKO) mice are glucose intolerant [24]. Moreover, we
recently demonstrated that mTORC2 is necessary for normal insulin-1Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Facu
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gested that mTORC2 is required for adrenergic stimulation of glucose
uptake in skeletal muscle [35]. Despite its position upstream of Akt
within the insulin signaling network, questions remain about how
mTORC2 signaling impacts glucose metabolism speciﬁcally in muscle,
because Akt signaling to substrates appears to be normal in muscle
lacking mTORC2 activity [3,22,35]. For example, in response to a
physiological insulin stimulation in vivo, phosphorylation of AS160, a
well described Akt substrate and key regulator of glucose uptake, was
not inhibited, but hyper-phosphorylated in muscle lacking RICTOR,
despite a robust reduction in Akt Ser473 phosphorylation [22] in Ric
mKO muscle.
Since muscle is an important tissue for whole-body glucose homeo-
stasis, especially in humans [12,20], understanding mTORC2-
mediated regulation of energy metabolism may reveal new thera-
peutic strategies for treating diseases that are characterized by dys-
regulated glucose metabolism (e.g. type 2 diabetes). We have recently
shown that acute inhibition of both mTOR complexes increases whole-
body lipid utilization in mice, while mTORC1 inhibition had no effectlty of Science, University of Copenhagen, Copenhagen, Denmark 2Charles Perkins
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[22]. We therefore hypothesized that, in addition to its role in glucose
metabolism, mTORC2 regulates lipid metabolism. In agreement with
our hypothesis, we found evidence for mTORC2 regulation of muscle
lipid metabolism, speciﬁcally lipid storage, which appears to be linked
to speciﬁc changes in the mTORC2-controlled proteome.
2. MATERIAL AND METHODS
2.1. Animals
Female muscle-speciﬁc RICTOR knockout (Ric mKO: RICTORﬂoxed/ﬂoxed,
HSA-Cre/þ) and WT (Ric WT: RICTORﬂoxed/ﬂoxed, HSA-Cre/) litter-
mates aged 9e16 weeks were used [3]. Female C57Bl/6 mice over-
expressing a muscle-speciﬁc, kinase-dead AMPKa2 construct (AMPK
KD) and corresponding WT littermates [30], aged 12e21 weeks were
used. Muscle-speciﬁc FoxO1 knockout muscle samples (FoxO1 mKO)
on a C57BL/6 background were a gift from Dr. Febbraio, Baker Heart
and Diabetes Institute, Melbourne, Australia. Mice were group-housed
when possible, kept on a 12:12-h lightedark cycle, and had free
access to standard rodent chow diet (Altromin no. 1324; Brogaarden,
Denmark) and water. All experiments were approved by the Danish
Animal Experimental Inspectorate.
2.2. qRT-PCR
Ric mKO mice:w20 mg quadriceps was homogenized in TRIzol (Life
Technologies). Total RNA was isolated using 1-Bromo 3-
Chloropropane for phase separation and isopropanol for total RNA
precipitation according to manufacturer’s instructions. RNA quantity
and purity was determined by UV measurements using a Nanodrop
ND-1000. cDNA was synthesized from all samples at the same time
using the same batch of enzyme mix from 1 mg total RNA using reverse
transcriptase and oligo-dT primers (Omniscript RT kit, Qiagen). The
primer sequences are listed in the Supplementary data online. Light-
Cycler 480 SYBR Green 1 Master Mix and LightCycler 480 (both Roche
Applied Science) were used to quantify cDNA. The PCR cycle condi-
tions were 94 C for 10 min followed by 40 cycles at 94 C for 15 s,
60 C for 30 s, and 72 C for 30 s. Assay efﬁciencies were checked
using serial dilution of mouse cDNA, and only primers that fell in the
85e115% range were used. Gene expression levels were normalized
to the house-keeping gene, EEF2 or HRPT, (no Ct difference between
Ric WT and mKO) and made relative to the Ric WT condition using the
DDCt method. AMPK KD mice: Total RNA was isolated fromw20 mg
AMPK KD and wildtype quadriceps muscle with a modiﬁed guanidi-
nium thiocyanate-phenol-chloroform extraction method adapted from
Chomczynski and Sacchi [10], described previously by Pilegaard et al.
[33], except that the tissue was homogenized for 3 min at 30 Hz in a
TissueLyzerII (Qiagen, CA, USA). RNA concentration and purity was
tested by Nanodrop (Nanodrop 1000, Thermo Scientiﬁc, MA, USA).
4 mg RNA was transcribed to cDNA by Superscript II RNase H system
and Oligo dT (Invitrogen, USA) [33]. mRNA content was determined in
triplicates by real-time PCR (ABI PRISM 7900 Sequence Detection
Systems; Applied Biosystems) using the ﬂuorogenic 50 nuclease assay
with TaqMan probes and universal mastermix with UNG using the
following cycle proﬁle: 50 C for 2 min þ 95 C for 10 min þ (95 C
for 15 s þ 60 C for 1 min)  40. PLIN3 and b-actin probes and
primers were pre-developed assay reagents from Applied Biosystems,
USA (PLIN3 # mm04208646_g1 and b-actin # 4352341E). The total
amount of PLIN3 and b-actin mRNA was determined by gene-speciﬁc
standard curves made from a serial dilution of a pooled sample made
from all samples. PLIN3 mRNA was normalized to total amount of b-
actin mRNA, and there was no difference in b-actin mRNA between
AMPK KD and wildtype. L6 cells and C2C12 cells: Total RNA wasMOLECULAR METABOLISM 5 (2016) 646e655  2016 The Author(s). Published by Elsevier GmbH. This is an
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performed using PrimeScript 1st strand cDNA Synthesis Kit (Clontech,
Takara Bio Company). PCR reactions were carried out using FastStart
Universal SYBR Green Master (Roche) on the LightCycler 480 II (Roche).
b-actin (Actb) or HRPT were used as internal controls and gene
expression levels were normalized to Actb or HRPT and made relative
to the control condition using the DDCt method. Primers used in L6
cells: Plin3 F: 50-CCTGATTGCCACATCTCCA-30; Plin3 R: 50-
GCCCAACCTGACAAAGTAGC-30; Actb F: 50-CTGGCTCCTAGCACCATGA-
30; Actb R: 50-ACTCCTGCTTGCTGATCCAC-30; and FoxO1 F: 50-GGA-
TAAGGGCGACAGCAACA-30; FoxO1 R: 50-TTCCCACTCTTGCCTCCCT-30.
Primers used in C2C12 cells: HRPT: F: 50-AAGCTTGCTGGTGAAAAGGA-
30; HRPT R: 50-TTGCGCTCATCTTAGGCTTT-30; Plin3 F: 50-GCCCAA-
GAGATGGTGTCTAGC-30; Plin3 R: 50-CCGGTCACTACGGACTTTGT-30.
Their efﬁciency was tested.
2.3. Nuclear fractionation
As adapted from Senf et al. [37] with minor changes. w30 mg of
quadriceps muscle from fed Ric mKO and AMPK KD mice were ho-
mogenized. The nuclear pellet was rotated for 2 h with 0.42 M NaCl. In
pilot experiments efﬁcient separation of the nuclear fraction from the
cytosolic fraction was veriﬁed with b-actin (cytosolic marker) and
lamin A/C (nuclear marker).
2.4. TG determinations
Muscle (quadriceps) and liver were freeze-dried and dissected free of
all visible fat, blood and connective tissue and IMTG and liver TG
content was assayed as previously described [21]. TG determinations
in C2C12 myotubes were carried out as described in [36].
2.5. PLIN3 overexpression experiments
C2C12 cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) (Invitrogen) containing antibiotics and 10% FCS. To differen-
tiate cells into myotubes, cells were maintained in DMEM (containing
antibiotics) now supplemented with 2% HS (differentiation medium) for
5e6 days. PLIN3 overexpression was accomplished by Lipofectamine-
2000 mediated transfection with a pCMV-Myc-C PLIN3 ORF clone.
Control cells were transfected with a pCAG-GFP empty vector clone. To
verify transfection myc-tag and GFP levels were assessed by standard
WB technique and PLIN3 expression was assayed by qPCR 24 h post
transfection. Other transfected myotubes were ﬁxed with 4% para-
formaldehyde and Dapi stained after 24 h. Staining intensity ﬂuores-
cence was measured at 340/460 nM. Other transfected myotubes
were incubated for 6 h or 18 h with either 750 mmol/L palmitic acid
made up in differentiation medium containing 2% BSA (free of fatty
acids) or for 18 h in differentiation medium only containing 2% BSA.
2.6. Western blot analysis
Tissues were homogenized with stainless steel pellets that shook
2  45 s at 30 Hz using a Tissuelyser II (Qiagen, USA) in ice-cold
homogenization buffer (10% Glycerol, 20 mM Na-pyrophosphate,
150 mM NaCl, 50 mM HEPES (pH 7.5), 1% NP-40, 20 mM b-glyc-
erophosphate, 10 mM NaF, 2 mM PMSF, 1 mM EDTA (pH 8.0), 1 mM,
EGTA (pH 8.0), 10 mg/ml Aprotinin, 10 mg/ml Leupeptin, 2 mM
Na3VO4, 3 mM Benzamidine, 5 mM Nicotinamide). Homogenates were
rotated end-over-end for 1 h at 4 C, and cleared by centrifugation at
13000 g for 20 min at 4 C. Lysate protein content was determined
by bicinchoninic acid method and lysates were diluted to the same
protein concentration (1e2 mg/ml). Total protein and phosphorylation
levels of indicated proteins were determined by standard immuno-
blotting, loading equal amounts of protein (5e40 ug).open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 647
Original article2.7. Indirect calorimetry and total activity
Mice were acclimatized to indirect calorimetry cages (PhenoMaster,
TSE, Germany) for 3 days, before expired carbon dioxide (VCO2) and
inhaled oxygen (VO2) were measured over another 3 days to deter-
mine respiratory exchange ratio (RER). Total activity was measured
with laser beam breaks and in a subset of mice food intake was
measured.
2.8. Body composition
Mouse body composition was assessed by MRI-scan (EchoMRI-4 in
1TM for Live Animals, Echo Medical System LLC, Texas, USA) ac-
cording to manufacturer’s instructions.
2.9. L6 cell experiments
2-DG Experiments: L6 myoblasts (ATCC CRL-1458) were grown in
growth media (a-MEM media (GIBCO #1257-063), 10% fetal bovine
serum (GIBCO #26140-038), 100 units/mL penicillin, 100 mg/ml
streptomycin, 0.25 mg/ml Fungizone (GIBCO #15240-062)) in 5%
CO2, at 37 C. For experiments, L6 myoblasts were seated in 6-well
plates. Once conﬂuent growth media was refreshed (2 ml) and in-
terventions as indicated were added. 2-deoxyglucose (2-DG, Sigma)
was made up as 2.5 and 0.25 M stock solution in distilled water and
added to wells at 1:100 resulting in ﬁnal concentration of 25 mM and
2.5 mM. Control wells received equal volumes of distilled water. A
Compound C (Calbiochem) stock solution of 1 mM in 100% DMSO
was diluted to 0.1 mM Compound C and 10% DMSO with distilled
water and ﬁnally added to wells at 1:100 for a ﬁnal concentration of
1 mM Compound C and 0.1% DMSO. Control wells received the same
concentration and volume of DMSO. After 16 h cells were washed
once with ice-cold PBS and lysed for WB: Cells were quickly dried,
and scraped off in presence of 150 ml ice-cold cell lysis buffer
(50 mM HEPES, 150 mM NaCl, 100 mM NaF, 10 mM sodium-
pyrophosphate, 5 mM EDTA, 250 mM sucrose, 1 mM DTT, 1% (v/
v) Triton X-100, 1 mM sodium orthovanadate, 1:100 protease in-
hibitor cocktail (#11697498001; Roche Applied Science; stock
solution ¼ 1 tablet in 0.5 ml distilled water), 5 mM Nicotinamide, pH
7.4). Cells were rigorously pipetted up and down 20 times and then
centrifuged at 13000 g for 10 min at 4 C. Supernatant (lysate)
protein content was determined with the bicinchoninic acid (BCA)
method using BSA standards (Pierce) and BCA assay reagents
(Pierce) and all lysates were diluted to the same protein concen-
tration (0.25e0.5 mg/ml). Total protein and phosphorylation levels of
indicated proteins were determined by standard immunoblotting,
loading equal amounts of protein (5e10 mg). AMPK activation ex-
periments: L6 myoblasts were initially cultured as above, but without
antibiotics. To differentiate myoblasts into myotubes fetal bovine
serum concentration was reduced to 2%. Myotubes were used for
experiments 5e9 days after the initiation of differentiation. To assess
the effect of AMPK activation on PLIN3 expression, L6 cells were
treated with 0.1% DMSO, 2 mM AICAR (Toronto Research Chemicals;
in PBS) þ 0.1%DMSO, 100 mM A-769662 (a kind gift from Dr. K.
Sakamoto; in 0.1% DMSO) or both compounds. Cells were also
treated with vehicle 10 mM Compound C where indicated (Calbio-
chem; in 0.1% DMSO). After 16 h cells were harvested for qPCR
analysis (described elsewhere). Knockdown of FoxO1, and FoxO3
experiments: L6 myoblasts cultured as above, but without antibiotics,
were transfected with scrambled siRNA, FOXO1-speciﬁc siRNA and/
or FOXO3-speciﬁc siRNA using RNAiMax (Life Technologies)
following the manufacturer’s instructions. For knockdown of each
FoxO isoform (1 and 3), cells were treated with a ﬁnal concentration
of 100 nM siRNA made up of equal amounts of a pool of three siRNAs648 MOLECULAR METABOLISM 5 (2016) 646e655  2016 The Author(s). Published by Elsefor FOXO1 and two siRNA for FOXO3 (see sense sequences below).
For simultaneous knockdown of both isoforms cells were treated with
100 nM of each siRNA pool (data of these experiments in Figure 5Fe
H). In separate experiments the effects of the individual FoxO1 siRNA
sequences were assessed (results in Figure S3) essentially as above
but with 100 nM of each siRNA. Assessment (by WB and qPCR) of the
effect of AMPK activation on PLIN3 expression was performed as
described above 36e48 h after transfection. Scramble, FoxO1 and
FoxO3 siRNAs were from GenePharma. For WB analysis, cells were
lysed in 2% SDS in PBS containing protease (Roche) and phospha-
tase inhibitors (1 mm sodium pyrophosphate, 2 mm sodium ortho-
vanadate, 10 mm sodium ﬂuoride) and protein content determination
and immunoblotting was carried out as described above. qPCR
analysis is described elsewhere. Knockdown of AMPKa: For siRNA
knockdown of the AMPKa catalytic subunits, siRNA oligonucleotide
sequences were purchased from Shanghai GenePharma Co., Ltd to
target either rat AMPKa1 or rat AMPKa2. For all siRNA knockdown
experiments rat L6 myoblasts were transfected at approximately 48 h
post seeding (or w60% conﬂuency). Calcium phosphate-based
siRNA transfection was utilized for each well of L6 myoblasts
seeded in a 6-well plate as follows, 3 ml of 20 mM Negative Control
scrambled or 1.5 ml of each AMPKa siRNA oligonucleotide was
added to 42.6 ml Buffer A (1 mM Tris/HCl, 0.1 mM EDTA, pH 7.9).
After mixing, 2.4 ml 1M CaCl2 was added dropwise followed by
another 12 ml 1M CaCl2. This siRNA mixture was then added
dropwise to 60 ml Buffer B (50 mM HEPES pH 7.0, 280 mM NaCL,
0.75 mM Na2HPO4, 0.75 mM NaH2PO4). After 30 min incubation at
room temperature, 120 ml of the combined siRNA mix was added
dropwise to myoblasts in 6-well plates containing 1380 ml
aMEM þ10% FBS and incubated 12e16 h. Following 12e16 h
incubation, media was aspirated and replaced with aMEM þ10%
FBS. Cells were harvested for experimentation 72 h after trans-
fection. The sense (50-30) sequences of the siRNA oligonucleotides
used are as follows: GAGGAUUGAACCAGUAUAATT (FoxO1_1),
CCAGGCACCUCAUAACAAATT (FoxO1_2), CAGCAAUGAUGACUUU-
GAUTT (FoxO1_3), GCACCAUGAAUCUGAACGATT (FoxO3_1), CCCU-
CAUCUCCACACAGAATT (FoxO3_2), CGAGUUGACUGGACAUAAATT
(AMPKa1), GCAACUAUCAAAGACAUACTT (AMPKa2), UUCUCCGAAC-
GUGUCACGUTT (Scramble).
2.10. Statistical analyses of non-omic data
Results are means  SEM. Statistical testing was performed using
two-tailed t-tests when comparing two means or analysis of variance
(ANOVA) with Holm Sidak test when comparing more than two means.
Statistical evaluation was performed using SigmaPlot 11.0. The sig-
niﬁcance level was set at p < 0.05.
2.11. Additional information
Material and methods for the proteomics and metabolomics studies as
well as the antibodies and primers used can be found in the
Supplementary data.
3. RESULTS
3.1. Muscle mTORC2 regulates lipid metabolism
Ric mKO mice had a lower respiratory exchange ratio (RER) (Figure 1A
and B), indicating an increased reliance on lipid metabolism. Loco-
motor activity was comparable between Ric WT and Ric mKO mice
(Figure 1C and D). Oxygen consumption (Ric WT: dark phase
3537 132 ml h1 kg1; light phase 2964 121 ml h1 kg1 vs Ric
mKO: dark phase 3540  151 ml h1 kg1; light phasevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1: mTORC2/Rictor in skeletal muscle regulates body composition, muscle triglyceride content and substrate utilization. (A,B) Respiratory exchange ratio (RER)
(n ¼ 10) and (C,D) total activity determined over three days with 12 h lightedark cycles (n ¼ 6). (E) Triglyceride content in dissected quadriceps from 12 h fasted mice (n ¼ 6e8).
(FeH) Body mass and fat and lean mass determined by MRI scanning at the indicated ages in ad libitum chow fed Ric WT and Ric mKO mice (n ¼ 8e9). *p < 0.05 main effect of
genotype (Ric WT vs Ric mKO). Values are means  SEM.2868 143 ml h1 kg1; n¼ 10) and food intake (Ric WT dark phase
2.8  0.2 g; light phase 1.0  0.1 g vs Ric mKO: dark phase
3.0  0.2 g; light phase 1.0  0.1 g; n ¼ 6e7) were also similar
between Ric WT and Ric mKO mice.
Ric mKO mice weighed the same as wildtype littermates (Figure 1F),
but their lean mass was decreased (Figure 1G) and their fat mass
increased (Figure 1H). At 28 weeks of age, Ric mKO mice hadw30%
(or w1 g) more fat mass. This was concomitant with an increase in
muscle fat content ofw65% more intramyocellular triglyceride (IMTG)
in Ric mKO muscle (Figure 1E). Triglyceride (TG) concentrations in the
liver were, as expected, unchanged (Figure S2A).
Metabolomic analysis of Ric WT and Ric mKO muscles identiﬁed 489
metabolites. Of those, 83 metabolites ([55, Y28 in Ric mKO) were
signiﬁcantly altered (p < 0.05) (Tables S1 and S2). Principal compo-
nent analysis indicated that lack of mTORC2 activity elicits a unique
biochemical proﬁle (Figure S1B). Unbiased random forest analysis
predicted the two genotypes (Ric WT vs Ric mKO) with an accuracy of
93.75% (Figure S1D) and the top 30 predictive metabolites are shown
in Figure S1D. Among these, amino acids were most prominently
represented (13 metabolites), followed by lipids (7 metabolites). Also,
three of the ﬁve most predictive metabolites were acetylated metab-
olites. In general, of the signiﬁcantly altered glucose metabolites the
majority was decreased in Ric mKO muscle, while lipid metabolites
tended to be increased (Figure S1C; Tables S1 and S2).MOLECULAR METABOLISM 5 (2016) 646e655  2016 The Author(s). Published by Elsevier GmbH. This is an
www.molecularmetabolism.comTo understand the mechanisms behind the changes in lipid metabo-
lites, substrate utilization and lipid storage in Ric mKO mice, we
performed quantitative proteomics by tandem mass spectrometry
(MS). This quantiﬁed 8,323 unique protein groups at a 1% false dis-
covery rate (FDR) in quadriceps muscles. Of those, 30 protein groups
were differentially expressed in Ric mKO muscle compared to Ric WT
muscle (adjusted P < 0.05) (Tables S3). 3-ketoacyl-CoA thiolase and
acyl-CoA dehydrogenase 10 (or 12), two enzymes of the b-oxidation
pathway, were increased in Ric mKO muscle (Figure S1A). There was a
trend (adjusted P ¼ 0.082) for increased protein expression of ATP
citrate lyase (Figure S1A), a key enzyme in synthesis of cytosolic acetyl
CoA. Perilipin 3 (PLIN3), a lipid droplet (LD)-coating protein, was highly
signiﬁcantly (adjusted P ¼ 0.001) regulated in Ric mKO muscles with
an increased expression of 85% (Figure S1A).
3.2. Robust overexpression of PLIN3 in Ric mKO skeletal muscle
Loss-of-function studies have implicated PLIN3 as a regulator of lipid
storage [6,7,39]. Given the increase in IMTG levels in muscle of Ric
mKO muscle, we focused on PLIN3. Protein expression of PLIN3,
measured by immunoblotting, was w5-fold higher in Ric mKO
muscle, conﬁrming the proteome data (Figure 2A and B). Gene
expression of PLIN3 was also elevated (w2-fold) in Ric mKO muscle
(Figure 2C). The protein expression of the perilipin family members,
PLIN2 and PLIN5, which have been implicated in the regulation ofopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 649
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Original articlemuscle lipid storage [5,15,28] was not altered in Ric mKO muscle
(Figure 2A and B).
3.3. FoxO1 is necessary for PLIN3 expression in skeletal muscle
In the liver, mTORC2 signals to the transcription factor forkhead box
protein O1 (FoxO1) via Akt [14]. We hypothesized that in muscle PLIN3
expression is FoxO1-dependent. Ric mKO muscle had increased nu-
clear FoxO1 content (Figure 2D) and gene expression of the FoxO1
target, atrogin-1, was increased (Figure 2F), indicating increased
transcriptional activity of FoxO1. In addition, protein expression of
PLIN3 was reduced by 64% in muscle from muscle-speciﬁc FoxO1
knockout mice (Figure 2E). Akt activity judged with the PAS antibody
was similar in Ric WT and Ric mKO muscle from fasted-refed mice
(Figure 2G), which was consistent with comparable phosphorylation
levels of the Akt target site S256 on FoxO1 in Ric WT and Ric mKO
muscle (Figure S2B).
3.4. AMPK activity is increased in Ric mKO mice and AMPK is
necessary for normal PLIN3 expression and IMTG levels
AMPK has been shown to modulate FoxO1 transcriptional activity [44].
In addition, our metabolomic data revealed an increase in endogenous
AICAR, an AMPK activator, in Ric mKO muscle, along with alterations in650 MOLECULAR METABOLISM 5 (2016) 646e655  2016 The Author(s). Published by Elsea number of other purine metabolites (Tables S1). Others have recently
reported increased AMPK activity following RICTOR knockdown in
smooth muscle cells [13]. We assessed AMPK activity by measuring
AMPKa Thr172 phosphorylation [38] in muscle from saline or insulin
stimulated Ric WT and Ric mKO mice. Insulin increased p-Akt Thr308
(Figure 3A and B). Decreased p-PKCa Ser657 and p-Akt Ser473 in Ric
mKO muscle is consistent with RICTOR deletion (Figure 3A and B).
AMPKa Thr172 phosphorylation was elevated in Ric mKO mice by
w30% with both saline and insulin stimulation compared to Ric WT
mice (Figure 3A and B), while protein expression of either the AMPKa1
or AMPKa2 subunits were similar (Figure 3A and B).
Akt can inhibit AMPK activation by phosphorylating AMPK on the
Ser485 residue [16], but while insulin injection increased AMPK
Ser485 phosphorylation (main effect; Figure 3A and B), there was no
difference in phosphorylation of AMPK Ser485 between Ric WT and Ric
mKO muscles (Figure 3A and B).
In muscles over-expressing a kinase-dead a2 AMPK subunit (AMPK
KD), which reduces overall AMPK activity [19,30], PLIN3 protein
expression was decreased tow47% of the WT level (Figure 4A and B).
This was accompanied by a w2-fold reduction in PLIN3 gene
expression (Figure 4C) and a decrease in nuclear FoxO1 content
(Figure 4D) in AMPK KD muscles. Akin to Ric mKO muscle, changes invier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 3: AMPK activity is increased in Ric mKO muscle. (A,B) Representative blots and quantitative analysis of indicated phosphorylation sites and total proteins in
quadriceps muscle from Ric WT and Ric mKO mice 10 min after i.p. saline or insulin (2.5 U/kg) injection (n ¼ 11e12, except for Akt2 blots where the n ¼ 8e9). ***p < 0.001,
**p < 0.01, and *p < 0.05 main effects of genotype (Ric WT vs Ric mKO); ###p < 0.001, ##p < 0.01 are insulin effects compared to corresponding basal; ¤p < 0.05 main
effect of insulin; ￥￥￥p < 0.001 genotype effect within saline injection. Values are means  SEM.PLIN3 expression were independent of changes in PLIN2 and PLIN5
protein content in AMPK KD muscles (Figure 4A and B). AMPK KD
muscle exhibited a w50% decrease in IMTG levels (Figure 4E). In
summary, the data from the AMPK KD muscle were reciprocal to the
ﬁndings in Ric mKO muscle.
3.5. AMPK agonism induces PLIN3 expression
We next asked whether AMPK activation is sufﬁcient to increase PLIN3
protein expression in muscle cells. We treated muscle cells with the
glycolysis inhibitor 2-deoxyglucose (2-DG) to activate the energy
sensor AMPK. 2-DG treatment decreased glycolysis, as assessed by
media lactate concentration (Figure 5A) and induced AMPK phos-
phorylation (Figure 5B and C). This increase in AMPK activity was
associated with an increase in PLIN3 protein expression (Figure 5B and
D). The AMPK inhibitor Compound C inhibited the 2-DG-induced in-
crease in AMPK phosphorylation as well as PLIN3 expression
(Figure 5BeD). AMPK activation with combined treatment with AMPK
agonists, AICAR and A769662, induced a marked increase in PLIN3
gene expression (Figure 5E) in muscle cells. This AMPK-induced PLIN3
expression was blunted by the AMPK inhibitor Compound C (Figure 5E)
and by siRNA mediated knockdown of AMPKa subunits (Figure S3A).
We further hypothesized that AMPK-mediated PLIN3 expression re-
quires FoxO1. AMPK agonism in conjunction with siRNA-mediated
knockdown of FoxO1 and FoxO3 revealed that FoxO1, but not
FoxO3, is obligatory for AMPK-mediated PLIN3 expression in muscle
cells (Figure 5FeH and Figure S3B and C).
3.6. PLIN3 overexpression increases muscle cell triglycerides
To understand whether the increase in IMTG levels in RICTOR-deﬁcient
muscles is directly linked to PLIN3, we overexpressed PLIN3 (Myc-
PLIN3) and a control GFP-tagged empty vector (GFP-EV) constructs in
muscle cells (Figure 6A and B). Transfection with Myc-PLIN3 or GFP-EV
had no apparent effect on cell viability, as judged with Dapi stainingMOLECULAR METABOLISM 5 (2016) 646e655  2016 The Author(s). Published by Elsevier GmbH. This is an
www.molecularmetabolism.com(Figure 6C). Incorporation of palmitate into TG increased 2-fold over
control GFP-EV after 16 h in PLIN3 overexpressing cells (Figure 6D).
This indicates that PLIN3 is sufﬁcient to increase TG content and
therefore suggests that in Ric mKO muscle the increase in PLIN3 drives
the increase in IMTG.
4. DISCUSSION
We here provided new evidence that mTORC2 regulates substrate
utilization, lipid metabolites and lipid storage, emphasizing the
importance of mTORC2 in muscle metabolism. With regards to lipid
storage, we identiﬁed a hitherto unknown link between PLIN3 and
mTORC2 activity, as mTORC2, via PLIN3, is a negative regulator of
IMTG levels. In contrast, AMPK appears to be a positive regulator of
PLIN3 expression and IMTG content.
Previously it has been shown that PLIN3 deletion decreased TG content
[6,7,39] and inhibited the maturation of lipid droplets [7] in cells. Virus-
mediated knockdown of PLIN3 in the liver of high-fat diet fed mice
improved hepatic steatosis along with glucose homeostasis [9]. Our
present results complement these ﬁndings, as we show that PLIN3 is
sufﬁcient to increase TG content. Moreover, it was previously unknown
what regulates PLIN3 expression in muscle. PLIN2 and PLIN5 are
regulated by PPARd and HFD in muscle, while PLIN3 was unresponsive
[4]. Our data indicates that PLIN3 expression requires, at least partially,
FoxO1 and that AMPK is a positive regulator of PLIN3. Whether the
PLIN3-mediated increase in IMTG in Ric mKO muscle contributes to the
insulin resistance in Ric mKO mice [22] will have to be determined.
In the current study we focused on PLIN3, but other RICTOR-regulated
proteome “hits” are of future interest. The protein phosphatase 1
regulatory subunit 1A (Ppp1r1a) was increasedw1.6-fold in Ric mKO
muscle. Ppp1r1a may play a regulatory role in glycogen metabolism
[32] and Ric mKO mice have elevated glycogen levels [22]. Another
observation was the marked decrease in paraoxonase 3 (PON3) proteinopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 651
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Figure 4: AMPK is necessary for PLIN3 expression. (A,B) Representative western blots and quantitative analysis of PLIN3, PLIN2 and PLIN5 protein expression from WT
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means  SEM.
Original articlecontent in Ric mKO muscle. PON3 is a member of the paraoxonase
family, which includes PON1 and PON2. PON proteins are generally
known as high-density lipoprotein (HDL)eassociated proteins that
have anti-oxidative, cardioprotective and antiatherogenic properties
[8]. In addition, PON proteins have been linked to insulin sensitivity
[18,41]. This is noteworthy given the previously reported insulin
resistance in the Ric mKO mice [22]. Deﬁciency of PON1 leads to
glucose intolerance as well as glycogen accumulation in muscle, while
forced overexpression of PON1 in muscle cells enhances GLUT4
expression [23].
Similarly, the metabolomics data should provide inspiration for future
follow-up studies. With regards to glycogen metabolism, it is of note
that multiple glycogen metabolites including maltotetraose, malto-
triose, and maltose were diminished in Ric mKO muscle. Maltotriose
and maltose were among the 30 most predictive and their low levels
may reﬂect limited glycogen availability or diminished breakdown. Also
among the top 30 list were oxidized glutathione (GSSG) and cysteine-
glutathione disulﬁde, both elevated in Ric mKO muscle. This could
indicate increased free radical exposure. In agreement, the oxidative652 MOLECULAR METABOLISM 5 (2016) 646e655  2016 The Author(s). Published by Elsestress marker ophthalmate (a tripeptide analogue of glutathione in
which cysteine is replaced by 2-aminobutyrate) also accumulated in
Ric mKO muscles. Conversely, histidine-derived antioxidants, such as
carnosine, N-acetylcarnosine, and anserine were signiﬁcantly dimin-
ished in Ric mKO muscle compared to Ric WT counterparts. These
metabolic “hits” will need to be validated, but together with other lines
of evidence they may give rise to future hypotheses.
FoxO1 is transcriptionally inactive in the cytosol and active in the
nucleus. FoxO1 localization is tightly regulated and matched to the
cell’s energy status by posttranslational modiﬁcations, such as
phosphorylation. Akt-mediated phosphorylation of FoxO1 leads to
nuclear export of FoxO1 [1]. Conversely, diminished Akt activity, with
the subsequent decrease in FoxO1 phosphorylation, results in an
enrichment of FoxO1 in the nucleus. As in the RICTOR-deﬁcient liver
[14], we detected increased nuclear content of FoxO1 in Ric mKO
muscle. Yet, our data point to tissue differences (muscle vs liver) with
regards to how RICTOR KO impacts FoxO1. While Akt-mediated FoxO1
phosphorylation was impaired in the liver [14,43], we could not detect
decreased phosphorylation in muscle, consistent with a previousvier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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normal in Ric mKO muscle, as was the Akt target site on AMPK.
Previously, we have shown that phosphorylation of the Akt substrates,
AS160 and GSK3, was not impaired in Ric mKO muscle [22]. It cannot
be ruled out that Akt activity towards speciﬁc substrates is blunted,
but it seems that in vivo Akt activity is largely normal in Ric mKO
muscle.0
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proposed that AMPK phosphorylates FoxO1 to increase FoxO1 tran-
scriptional activity [44]. What causes the increase in AMPK activity
observed by us presently in muscle and by others previously in cells
[13] requires future investigations. It is not clear whether the 50%
increase in endogenous AICAR is sufﬁcient to affect AMPK activity in
Ric mKO muscle and we cannot rule out that other upstream0.0
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Original articleregulators, changes in the overall energy state, or stress signaling
pathways are underpinning the elevation in AMPK activity in Ric mKO
muscle.
Our ﬁnding that AMPK is involved in muscle lipid storage is a bit
perplexing, given that AMPK activity is generally thought to promote
glucose and lipid catabolism to provide energy substrates in times of
cellular energy paucity. Activation of AMPK increases both glucose and
lipid oxidation in resting muscle [29], but whether AMPK also plays a
role in energy storage has not been thoroughly investigated. However,
chronic activation of AMPK gamma1 in muscle increases glycogen
levels [2], gain-of function gamma2 mutation in the heart causes
massive glycogen accumulation [27] and AICAR-induced AMPK acti-
vation has also been shown to increase muscle glycogen in mice [17].
The role of AMPK in lipid storage IMTG is unclear, but our data should
spur future research into AMPK-regulated IMTG turnover, especially
since exercise training (i.e., repeated AMPK activation) can lead to
elevated IMTG levels [40].
5. CONCLUSIONS
In conclusion, we have characterized new aspects of mTORC2 and
AMPK biology in muscle lipid metabolism by showing that mTORC2
and AMPK are, respectively, negative and positive regulators of lipid
storage via PLIN3. In addition, lack of mTORC2 activity in muscle
caused a greater reliance on fat as an energy substrate and re-
partitioning of lean to fat mass.
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